Alnylam Pharmaceuticals
ALNY
#563
Rank
C$57.26 B
Marketcap
C$431.81
Share price
-0.47%
Change (1 day)
24.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company